comparemela.com
Home
Live Updates
Cynata completes strategic review of development portfolio : comparemela.com
Cynata completes strategic review of development portfolio
Cynata Therapeutics Ltd (ASX:CYP) CEO Dr Kilian Kelly speaks with Proactive following the completion of a strategic review of the company’s clinical...
Related Keywords
Kilian Kelly
,
Cynata Therapeutics Ltd
,
comparemela.com © 2020. All Rights Reserved.